New device may help spot hidden precancerous polyps
NCT ID NCT07601230
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests a new device that flattens colon polyps before they are examined under a microscope. The goal is to help doctors better identify sessile serrated lesions, a type of polyp that can lead to colorectal cancer. About 1,156 adults having polyps removed during a colonoscopy will take part. The device is meant to improve accuracy and catch more precancerous growths.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
About 1,156 people
The number the study aims to enrol. It can still change while the study runs.
- Expected to start
-
Jun 2026
An estimate. Start dates often move.
- Expected to finish
-
May 2028
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Accepted
You do not need to have the condition being studied to take part.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: 1. Patients undergoing colonoscopic polypectomy (≤3 lesions if multiple). 2. Sessile/flat polyps (Paris 0-Is,0-IIa, 0-IIb, 0-IIc) resected by snare or EMR with intact specimens. 3. Signed informed consent. Exclusion Criteria: 1. Refusal or lack of informed consent. 2. Polyp size ≥25 mm or fragmented resection. 3. Severe specimen damage/cautery artifact or time from resection to fixation \>30 min. 4. Suspected/confirmed CRC, IBD, or polyposis syndromes. 5. Anticoagulants (aspirin/warfarin) within 7 days or coagulation disorders.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Sessile serrated lesion are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Study seeks clues to predict who needs closer colon checks after polyp removal
- AI eye on the colon: new trial tests smart detection for sneaky polyps
- Dye spray boosts Colonoscopy's hidden polyp detection
- AI tool aims to sharpen colonoscopy diagnoses
- Stool test could spot colon cancer early, study hopes
- AI eye in the colon: new study aims to catch hidden polyps